Swiss National Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.86M | Hold |
161,052
| – | – | ﹤0.01% | 1189 |
|
|
2025
Q1 | $5.83M | Sell |
161,052
-2,100
| -1% | -$76K | ﹤0.01% | 1176 |
|
|
2024
Q4 | $6.86M | Buy |
163,152
+4,000
| +3% | +$168K | ﹤0.01% | 1132 |
|
|
2024
Q3 | $8.84M | Buy |
159,152
+13,300
| +9% | +$739K | 0.01% | 1003 |
|
|
2024
Q2 | $5.99M | Hold |
145,852
| – | – | ﹤0.01% | 1154 |
|
|
2024
Q1 | $6.81M | Buy |
145,852
+4,300
| +3% | +$201K | ﹤0.01% | 1106 |
|
|
2023
Q4 | $6.77M | Sell |
141,552
-14,100
| -9% | -$674K | 0.01% | 1098 |
|
|
2023
Q3 | $5.55M | Buy |
155,652
+2,800
| +2% | +$99.8K | ﹤0.01% | 1218 |
|
|
2023
Q2 | $7.05M | Buy |
152,852
+9,100
| +6% | +$420K | ﹤0.01% | 1102 |
|
|
2023
Q1 | $5.76M | Sell |
143,752
-16,900
| -11% | -$678K | ﹤0.01% | 1166 |
|
|
2022
Q4 | $7.44M | Buy |
160,652
+3,100
| +2% | +$144K | 0.01% | 1071 |
|
|
2022
Q3 | $6.52M | Buy |
157,552
+2,300
| +1% | +$95.2K | ﹤0.01% | 1120 |
|
|
2022
Q2 | $9.26M | Buy |
155,252
+2,100
| +1% | +$125K | 0.01% | 960 |
|
|
2022
Q1 | $11.1M | Buy |
153,152
+11,300
| +8% | +$821K | 0.01% | 964 |
|
|
2021
Q4 | $11.9M | Buy |
141,852
+200
| +0.1% | +$16.8K | 0.01% | 913 |
|
|
2021
Q3 | $12.8M | Buy |
141,652
+1,500
| +1% | +$135K | 0.01% | 878 |
|
|
2021
Q2 | $13.4M | Sell |
140,152
-3,400
| -2% | -$324K | 0.01% | 867 |
|
|
2021
Q1 | $16.3M | Buy |
143,552
+13,400
| +10% | +$1.53M | 0.01% | 753 |
|
|
2020
Q4 | $18M | Buy |
130,152
+1,500
| +1% | +$208K | 0.01% | 682 |
|
|
2020
Q3 | $10.6M | Buy |
128,652
+5,900
| +5% | +$485K | 0.01% | 785 |
|
|
2020
Q2 | $9.6M | Buy |
122,752
+16,300
| +15% | +$1.28M | 0.01% | 791 |
|
|
2020
Q1 | $4.73M | Buy |
106,452
+1,600
| +2% | +$71.1K | 0.01% | 966 |
|
|
2019
Q4 | $4.48M | Buy |
104,852
+2,000
| +2% | +$85.4K | ﹤0.01% | 1229 |
|
|
2019
Q3 | $4.4M | Buy |
102,852
+3,200
| +3% | +$137K | ﹤0.01% | 1173 |
|
|
2019
Q2 | $6.33M | Buy |
99,652
+1,400
| +1% | +$88.9K | 0.01% | 973 |
|
|
2019
Q1 | $6.82M | Buy |
98,252
+14,000
| +17% | +$971K | 0.01% | 912 |
|
|
2018
Q4 | $3.66M | Buy |
84,252
+2,200
| +3% | +$95.6K | ﹤0.01% | 1169 |
|
|
2018
Q3 | $6.26M | Hold |
82,052
| – | – | 0.01% | 976 |
|
|
2018
Q2 | $6.31M | Buy |
82,052
+4,400
| +6% | +$338K | 0.01% | 954 |
|
|
2018
Q1 | $3.96M | Buy |
77,652
+7,700
| +11% | +$393K | ﹤0.01% | 1190 |
|
|
2017
Q4 | $3.24M | Buy |
69,952
+2,700
| +4% | +$125K | ﹤0.01% | 1330 |
|
|
2017
Q3 | $3.58M | Buy |
67,252
+1,200
| +2% | +$63.9K | ﹤0.01% | 1240 |
|
|
2017
Q2 | $4.1M | Buy |
66,052
+2,100
| +3% | +$130K | ﹤0.01% | 1114 |
|
|
2017
Q1 | $4.34M | Buy |
63,952
+2,400
| +4% | +$163K | 0.01% | 1062 |
|
|
2016
Q4 | $4.33M | Buy |
61,552
+1,500
| +2% | +$105K | 0.01% | 1053 |
|
|
2016
Q3 | $4.26M | Sell |
60,052
-300
| -0.5% | -$21.3K | 0.01% | 1009 |
|
|
2016
Q2 | $2.95M | Buy |
60,352
+16,085
| +36% | +$787K | ﹤0.01% | 1211 |
|
|
2016
Q1 | $2.7M | Buy |
44,267
+8,900
| +25% | +$544K | 0.01% | 1248 |
|
|
2015
Q4 | $3.97M | Buy |
35,367
+500
| +1% | +$56.1K | 0.01% | 899 |
|
|
2015
Q3 | $3.36M | Buy |
34,867
+9,467
| +37% | +$912K | 0.01% | 994 |
|
|
2015
Q2 | $2.6M | Hold |
25,400
| – | – | 0.01% | 1148 |
|
|
2015
Q1 | $1.58M | Buy |
25,400
+6,200
| +32% | +$385K | ﹤0.01% | 1457 |
|
|
2014
Q4 | $842K | Buy |
19,200
+12,900
| +205% | +$566K | ﹤0.01% | 1831 |
|
|
2014
Q3 | $357K | Hold |
6,300
| – | – | ﹤0.01% | 2274 |
|
|
2014
Q2 | $283K | Buy |
+6,300
| New | +$283K | ﹤0.01% | 2406 |
|